🚀 Pharmidex at BioWednesday Stevenage 🚀
February 5, 2025
We are excited to share that our Business Development Manager, Janette Dalay Robertson, and Head of Operations,
Ash Alavijeh, had the pleasure of attending the BioWednesday Stevenage: Key Messages and Sentiments from JPM Week 2025 event today at the
Stevenage Bioscience Catalyst.
It was a fantastic opportunity to connect with industry leaders, potential clients, and partners. Janette and Ash were thrilled to engage in meaningful conversations, exploring new collaborations, and discussing the latest insights from JPM Week 2025.
At Pharmidex, we're committed to expanding our relationships and helping our clients navigate their path to success in drug discovery and development. Together, we’re working towards creating a healthier future.
A big thank you to everyone we had the pleasure of meeting today. We look forward to the continued conversations and collaborations!
#Pharmidex #BioWednesday #JPMWeek2025 #DrugDiscovery #Biotech #Innovation #Pharmaceuticals #Networking #StevenageBioScienceCatalyst
Pharmidex is pleased to share that Ash Alavijeh , our Head of Operations, will be attending the Life Sciences Wallonia Business Forum this evening at the Residence of the Belgian Ambassador. Hosted by the Economic Counsellor of Belgium-Wallonia Investment & Trade, the event brings together leading organisations across the European life sciences sector to explore how Wallonia supports international growth both financially and strategically. We look forward to connecting with international partners and exploring opportunities for collaboration and innovation in the European life sciences ecosystem.
Pharmidex is proud to sponsor the SMR meeting Target Identification and Validation in Drug Discovery
We’re excited that Janette Dalay Robertson (Business Development Manager) and Ian Knowles (Head of Respiratory) will attend, eager to meet attendees, share ideas and explore new collaborations to advance drug discovery and development. At Pharmidex , we know robust target validation is key to successful therapeutics. Our expertise in biomarker analysis, histology, in vivo models, and autoimmune disease research supports innovation across translational medicine.
Pharmidex is delighted to announce our joint poster with VasoDynamics Ltd at Scotland’s Health Research and Innovation Conference on October 23rd in Edinburgh! We’re proud to be part of this inspiring event, organised by NHS Scotland and CSO Scotland , which brings together the brightest minds driving progress in health research, innovation, and life sciences. 📍 Visit our stand to learn more about our collaborative work. A printout of the poster will be available. Mo Alavijeh (FRSC, FRSM ) is looking forward to meeting attendees and discussing new opportunities for partnership and discovery. Together with VasoDynamics Ltd , we’re advancing science through collaboration and innovation. 🔗 Learn more about Pharmidex : www.pharmidex.com
